Allopurinol promotes and butylated hydroxy toluene prevents sugar-induced cataractogenesis

Nassem H. Ansari, Satish K. Srivastava

Research output: Contribution to journalArticlepeer-review

33 Scopus citations


Rats fed a high galactose (30% galactose) diet ( w w) or made diabetic by injecting streptozotocin developed mature cataracts in approximately 45 and 90 days, respectively. Addition of allopurinol, a commonly used drug in the therapy of gout, to the high galactose diet or to the normal diet fed to diabetic rats advanced cataractogenesis in both the groups by approximately 50%. Allopurinol fed to control rats did not cause cataract formation. Feeding butylated hydroxy toluene (BHT), an antioxidant, prevented the allopurinol-induced advancement of cataract formation in galactosemic and diabetic rats. Assuming that these results are applicable in human subjects, there is need for caution in using allopurinol for the therapy of gout in diabetic subjects.

Original languageEnglish (US)
Pages (from-to)939-943
Number of pages5
JournalBiochemical and Biophysical Research Communications
Issue number3
StatePublished - May 16 1990

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology


Dive into the research topics of 'Allopurinol promotes and butylated hydroxy toluene prevents sugar-induced cataractogenesis'. Together they form a unique fingerprint.

Cite this